Related Experiment Video

Updated: May 21, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

Neoflavonoids and tetrahydroquinolones as possible cancer chemopreventive agents

Suaib Luqman1, Abha Meena, Pragya Singh

  • 1Molecular Bioprospection Department, Central Institute of Medicinal and Aromatic Plants-CSIR-CIMAP, Kukrail Picnic Spot Road, Lucknow 226015, India.

Chemical Biology & Drug Design
|June 26, 2012
PubMed

Insights

New neoflavonoids and tetrahydroquinolones show promise as cancer chemopreventive agents by inhibiting key molecular targets like nuclear factor kappa B (NFκB) and aromatase in vitro.

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Neoflavonoids and tetrahydroquinolones are classes of compounds with potential biological activities.
  • Cancer chemoprevention aims to prevent cancer development or recurrence using molecular targets.

Purpose of the Study:

  • To synthesize and evaluate novel lactone- and lactam-based neoflavonoids and tetrahydroquinolones for cancer chemopreventive potential.
  • To assess the inhibitory effects of these compounds on specific molecular targets involved in cancer pathways.

Main Methods:

  • In vitro bioassays were employed, focusing on nuclear factor kappa B (NFκB) activation, aromatase inhibition, and quinone reductase 1 (QR1) induction.
  • Compounds were tested for their dose-dependent effects on TNF-α-induced NFκB activation.
  • Specific compounds were evaluated for their IC₅₀ values against aromatase and their impact on QR1 induction.

Main Results:

  • Several synthesized analogs demonstrated potent inhibition of TNF-α-induced NFκB activation, with IC₅₀ values ranging from 0.11 to 3.2 μM.
  • Compound 8 effectively inhibited aromatase activity (IC₅₀ = 12.12 μM).
  • Compound 10 showed significant effects on quinone reductase 1 induction (Induction Ratio = 3.6; Concentration for 50% effect = 19.57 μM).

Conclusions:

  • Neoflavonoids 8 and 10 exhibit promising results for cancer chemoprevention and warrant further optimization for therapeutic development.
  • Further research, including in vivo studies, is recommended to elucidate the mechanisms of action, particularly concerning the NFκB signaling pathway, aromatase inhibition, and QR1 induction.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Facile Preparation of 4-Substituted Quinazoline Derivatives11:51

Facile Preparation of 4-Substituted Quinazoline Derivatives

Published on: February 15, 2016

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...